Dr. Lee Tessler Appointed to VirtualTrials.org Medical Advisory Board
ROCKVILLE, CENTRE, N.Y.,– Neurosurgeon Lee Tessler, M.D., F.A.A.N.S., F.A.C.S., Executive Director and Co-Surgical Director of The Long Island Brain Tumor Center at Neurological Surgery, P.C. (NSPC), has been appointed to the national Medical Advisory Board of VirtualTrials.org. Dr. Tessler is a resident of Port Washington, NY.
VirtualTrials.org is a project of The Musella Foundation for Brain Tumor Research & Information, Inc., a 501(c) 3 nonprofit public charity dedicated to helping brain tumor patients through emotional and financial support, education, advocacy and raising money for brain tumor research.
“Remarkable advances in immunotherapy, drug delivery options, as well as the drugs themselves used in clinical trials allow us to identify new and more effective ways to fight brain tumors,” said Dr. Tessler. “Being on the VirtualTrials.org Medical Advisory Board will allow me to join others in the field in helping determine the best treatment choices.”
In addition to providing a wide range of information on brain tumors, the latest treatments and clinical trials, the site allows brain tumor patients to participate in what founder and President Al Musella, D.P.M. calls a “virtual trial.” While not an actual clinical trial in which patients are given experimental treatments, the virtual trial is a study of brain tumor patients, their treatments and treatment outcomes.
According to the site: “The Brain Tumor Virtual Trial™ is a new concept in collecting and analyzing outcomes data for brain tumor patients. We collect information from brain tumor patients – or their friends / family, over the Internet. Participants are not told what treatments to do – we just record and analyze the outcomes of the treatments you and your doctors decide to try. The idea is to enable us to quickly identify which treatments or combinations of treatments look the most promising. We will then perform a traditional multi-center study on the best combinations of treatments.”
Dr. Tessler will be in good company on the board, which is composed of international leaders in brain cancer research and treatment. They represent such notable institutions as UCLA Medical Center, Duke University and the University of Pittsburgh Cancer Institute.
A board certified neurosurgeon, Dr. Tessler specializes in the treatment of primary brain tumors, metastatic tumors and meningiomas, using stereotactic surgery and radiosurgery. Dr. Tessler received his undergraduate degree cum laude from Duke University. He obtained his medical degree from The Ohio State University College of Medicine and Public Health. Dr. Tessler served both his internship and residency in the Department of Neurological Surgery at NYU Langone Medical Center, where he was named chief resident. In 2008, Dr. Tessler was appointed as Assistant Professor of Neurosurgery at NYU Langone Medical Center. He is currently Chief of Neurotrauma and Chairman of the Neurosurgery Quality Improvement Committee at Winthrop-University Hospital.
Dr. Tessler also serves on Voices Against Brain Cancer’s Medical Advisory Board. Among other honors, he is a recipient of the Community Service Award from the Aleh Foundation, which funds Israel’s largest provider of educational rehabilitative services to severely developmentally disabled children.
The Long Island Brain Tumor Center at Neurological Surgery, P.C. offers a multi-disciplinary approach to treating brain tumors, provided by a team of more than 20 physicians and surgeons with various sub-specialties. The team works in concert with patient’s established health care professionals, and treats primary brain and spinal tumors, as well as metastases.
In addition to offering standard-of-care therapies for brain tumors, and novel treatments such as NovoTTF, the Center is currently conducting a number of clinical trials. For more information about The Long Island Brain Tumor Center at NSPC, please visit www.braintumor.com or call (516) 478-0010. To learn more about VirtualTrials.org, visit www.virtualtrials.org.